⌘K

Home/Filings/4/0001424422-19-000011

4//SEC Filing

Bosacki Steven 4

Accession 0001424422-19-000011

CIK 0001504167other

View on SEC.gov Company Profile

Filed

Jul 17, 8:00 PM ET

Accepted

Jul 18, 5:41 PM ET

Size

5.2 KB

Accession

0001424422-19-000011

Insider Transaction Report

Form 4

Period: 2019-07-16

BioPharmX CorpBPMX

Chief Operating Officer

Transactions

Award
Option to purchase common stock
2019-07-16$0.44/sh+91,000$40,040→ 91,000 total
Exercise: $0.44From: 2019-08-31Exp: 2029-07-16→ Common stock (91,000 underlying)

Footnotes (1)

[F1]This option vests and becomes exercisable ratably over 36 months

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

BioPharmX Corp

CIK 0001504167

Entity typeother

Related Parties

1

filerCIK 0001782878

Filing Metadata

Form type: 4
Filed: Jul 17, 8:00 PM ET
Accepted: Jul 18, 5:41 PM ET
Size: 5.2 KB

View on SEC.gov